Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients

Sponsor

Riphah International University (Other)

Overall Status

Recruiting

CT.gov ID

NCT05285865

Collaborator

(none)

Enrollment

Location

Arms

10.6

Anticipated Duration (Months)

5.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To determine the effects of scapular mobilization on pulmonary functions of post-CABG patients.

Condition or Disease	Intervention/Treatment	Phase
CABG	Other: Conventional Treatment Other: Scapular Mobilization	N/A

Study Design

Study Type:

Interventional

Anticipated Enrollment :

60 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Supportive Care

Official Title:

Effects of Scapular Mobilization on Inspiratory Capacity of Post-CABG Patients

Actual Study Start Date :

Mar 15, 2022

Anticipated Primary Completion Date :

Feb 1, 2023

Anticipated Study Completion Date :

Feb 1, 2023

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Conventional Treatment Thrice a day ,Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.	Other: Conventional Treatment Thrice a day for complete length of stay. This is Conventional treatment The total duration of session will be of 15-20 mins.
Experimental: Scapular Mobilization Thrice a day Scapular mobilization (SM) along with Conventional treatment	Other: Scapular Mobilization Thrice a day for complete length of stay including two sets of repetitions with a rest interval of 30 seconds between sets. Grade 1-3 As reported in a study Scapular mobilization (SM) i.e., Scapular superior, inferior glides, upward and downward rotations and scapular distraction, along with Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.

Arm

Intervention/Treatment

Active Comparator: Conventional Treatment

Thrice a day ,Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.

Other: Conventional Treatment

Thrice a day for complete length of stay. This is Conventional treatment The total duration of session will be of 15-20 mins.

Experimental: Scapular Mobilization

Thrice a day Scapular mobilization (SM) along with Conventional treatment

Other: Scapular Mobilization

Thrice a day for complete length of stay including two sets of repetitions with a rest interval of 30 seconds between sets. Grade 1-3 As reported in a study Scapular mobilization (SM) i.e., Scapular superior, inferior glides, upward and downward rotations and scapular distraction, along with Conventional treatment according to American Heart Association Guidelines i.e., Incentive spirometer, chest clearance, expectoration of the sputum (suctioning if needed), mobilizing the patient out of bed, AAROM and AROM exercises.

Outcome Measures

Primary Outcome Measures

Incentive Spirometer [1 week]
An incentive spirometer is a device that will expand the lungs by helping the patient breathe more deeply and fully
Borg scale [1 week]
The Borg Rating of Perceived Exertion (RPE) is a way of measuring physical activity intensity level.
Numeric pain rating scale [1 week]
What is a numerical pain rating scale? The Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain
Digital Spirometer [1 week]
Spirometer is a portable lung function testing device, which mainly used to examine lung function related parameters for patients

Eligibility Criteria

Criteria

Ages Eligible for Study:

40 Years to 70 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

CAD patients undergone CABG surgery (Post-Op. Day#. 01).
Both genders (male and female).
Aged between 40 to 70 years .
Patient having oxygen saturation (SPO2) of more than or equal to 90% with 25% of fraction of inspired oxygen (FiO2) - (possibly nasal cannula inserted).

Exclusion Criteria:

Patients with low glasgow coma scale (GCS) score (less than 15).
Patients having inspiratory capacity of 3500ml and above.
Patients on ventilator.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Rehman Medical Institute	Peshawar	KPK	Pakistan	46000

Sponsors and Collaborators

Riphah International University

Investigators

Principal Investigator: Malik Muhammad Ali Awan, MSPT, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Riphah International University

ClinicalTrials.gov Identifier:

NCT05285865

Other Study ID Numbers:

REC/01278 Sakina Asghar

First Posted:

Mar 18, 2022

Last Update Posted:

May 5, 2022

Last Verified:

Apr 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Respiratory Aspiration

Study Results

No Results Posted as of May 5, 2022